Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Nature Communications
|
February 1, 2020
Author Correction: Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans
Khadijah A Mitchell, Noah Nichols, Wei Tang, et al.
Nature Communications
|
December 18, 2019
Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans
Khadijah A Mitchell, Noah Nichols, Wei Tang, et al.
The Oncologist
|
July 21, 2021
Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing
Wael Al Zoughbi, Jesse Fox, Shaham Beg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 27, 2019
Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses
Taofeek K Owonikoko, Huifeng Niu, Kristiaan Nackaerts, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Nature Communications
|
February 1, 2020
Author Correction: Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans
Khadijah A Mitchell, Noah Nichols, Wei Tang, et al.
Nature Communications
|
December 18, 2019
Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans
Khadijah A Mitchell, Noah Nichols, Wei Tang, et al.
The Oncologist
|
July 21, 2021
Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing
Wael Al Zoughbi, Jesse Fox, Shaham Beg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 27, 2019
Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses
Taofeek K Owonikoko, Huifeng Niu, Kristiaan Nackaerts, et al.
Page
of 3